Dolutegravir Sodium, Abacavir Sulfate and Lamivudine Tablets

ViiV Healthcare BV🇨🇳 National Medical Products Administration

Approval Id: 8HTcEID4Wot
Approval Number: 国药准字HJ20170345
Generic Name: 多替阿巴拉米片
Generic Name En: Dolutegravir Sodium, Abacavir Sulfate and Lamivudine Tablets
Trade Name: 绥美凯
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含多替拉韦钠(以多替拉韦计)50mg、硫酸阿巴卡韦(以阿巴卡韦计)600mg和拉米夫定300mg
Reg Date: 2022-05-23
Expired Date: 2027-05-22
Company Name: ViiV Healthcare BV
Company Address: Van Asch van Wijckstraat 55H, 3811 LP Amersfoort, Netherlands
Production Company Name: glaxo operations uk ltd (trading as glaxo wellcome operations)
Production Company Address: Priory Street, Ware, Hertfordshire SG12 0DJ, United Kingdom
Company Detail Path: /organization/viiv-healthcare-bv

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

May 23, 2022

Approval ID

8HTcEID4Wot

Type

化学药品